Related Experiment Video

Updated: Aug 10, 2026

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 17, 2009

Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells

N Sakata1, H R Patel, N Terada

  • 1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.

The Journal of Biological Chemistry
|December 22, 1995
PubMed

Insights

B cell receptors surface IgM (sIgM) and CD40 activate distinct protein kinase pathways. These parallel pathways regulate B cell function and survival, with CD40 also preventing sIgM-induced apoptosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Background:

  • B cell activation, proliferation, and survival are critical for adaptive immunity.
  • Surface IgM (sIgM) and CD40 are key B cell surface receptors with distinct roles in immune responses.
  • Understanding the signaling pathways downstream of these receptors is crucial for B cell function.

Purpose of the Study:

  • To investigate the distinct intracellular signaling pathways activated by B cell surface IgM (sIgM) and CD40.
  • To determine the interplay between sIgM and CD40 signaling in regulating B cell phenotype and function.
  • To elucidate the role of mitogen-activated protein kinase (MAPK) family members in mediating these responses.

Main Methods:

  • Stimulation of B cells with anti-IgM antibodies and anti-CD40 antibodies or soluble CD40 ligand.
  • Analysis of protein kinase activation, including Ras/Raf/p42erk2 and c-Jun kinase (JNK)/stress-activated protein kinase pathways.
  • Assessment of B cell apoptosis and rescue by CD40 ligation.

Main Results:

  • Cross-linking sIgM activates the Ras/Raf/p42erk2 pathway.
  • CD40 ligation activates the JNK/stress-activated protein kinase pathway, correlating with MEK kinase activity.
  • CD40 does not activate the p42erk2 pathway, and sIgM does not activate the JNK pathway.
  • Anti-CD40 rescued B cell apoptosis induced by anti-IgM.
  • Signaling pathways for sIgM and CD40 operate independently and in parallel.

Conclusions:

  • sIgM and CD40 differentially regulate distinct MAPK pathways in B cells.
  • These parallel signaling pathways are integrated to control B cell phenotype and function.
  • CD40 plays a protective role against sIgM-mediated B cell apoptosis.

More Related Videos

Murine Model of CD40-activation of B cells12:24

Murine Model of CD40-activation of B cells

Published on: March 6, 2010

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...